Epilepsy trials in Croatia

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  Where

  Rijeka

  Age

  12 years and over

  People

  160 worldwide

  Run by

  Xenon Pharmaceuticals Inc.

  See details and how to joinNCT05667142 · EU 2022-502286-16-00
• Phase 3Taking people
  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  Where

  Grad Zagreb, Rijeka

  Age

  18 years and over

  People

  360 worldwide

  Run by

  Xenon Pharmaceuticals Inc.

  See details and how to joinNCT05716100 · EU 2022-502281-25-00
• Phase 3Enrolling by invitation
  An Open-label Study of XEN1101 in Epilepsy

  Where

  Grad Zagreb, Zagreb

  Age

  12 years and over

  People

  880 worldwide

  Run by

  Xenon Pharmaceuticals Inc.

  See details and how to joinNCT05718817 · EU 2022-502282-24-00
• Phase 2Enrolling by invitation
  Long-term Safety and Tolerability of BHV-7000

  Where

  Grad Zagreb, Rijeka, Zagreb

  Age

  18 years to 75 years

  People

  660 worldwide

  Run by

  Biohaven Therapeutics Ltd.

  See details and how to joinNCT06443463 · EU 2023-508813-18-00